Pathway-Centric Comparative Molecular Profiling of Sézary Syndrome and Primary Cutaneous CD8<sup>+</sup> Aggressive Epidermotropic Cytotoxic T-Cell Lymphoma via Conversational Artificial Intelligence.

Cancers (Basel) · 2026 · PMC13162890 · PMID 42122184

Europe PMC DOI

hedged sentences

0.0000

closest p · 0.0× alpha

0.0000

boldest claim

The sentences

highly significantp ≈ 3.99 × 10 −9actually significant

As expected, subtype-defining clinical variables, including “Cancer Type Detailed” and “Subtype_Group”, showed highly significant differences between SS and PCAECTCL ( p ≈ 3.99 × 10 −9 ), validating cohort stratification.

also in 132,142 other papers

showed a trendno p-value reported

Alterations in DNA damage response pathways and apoptosis/immune regulatory mechanisms also showed a trend toward enrichment in SS, with the latter observed only in SS tumors (4% vs. 0%), albeit at low frequency.

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.

Pathway-Centric Comparative Molecular Profiling of Sézary Syndrome and Primary Cutaneous CD8&lt;sup&gt;+&lt;/sup&gt; Aggressive Epidermotropic Cytotoxic T-Cell Lymphoma via Conversational Artificial Intelligence.

The sentences

Pathway-Centric Comparative Molecular Profiling of Sézary Syndrome and Primary Cutaneous CD8<sup>+</sup> Aggressive Epidermotropic Cytotoxic T-Cell Lymphoma via Conversational Artificial Intelligence.